Why do women with melanoma do better than men?

por Smalley, Keiran SM
Publicado 2018

Inhibition of BRAF and BRAF+MEK drives a metastatic switch in melanoma

por Smalley, Keiran SM, Fedorenko, Inna V
Publicado 2015

Histone deacetylase inhibitors: a promising partner for MEK inhibitors in uveal melanoma?

por Faião-Flores, Fernanda, Smalley, Keiran SM
Publicado 2019

The complexity of microenvironment-mediated drug resistance

por Fedorenko, Inna V., Smalley, Keiran S.M.
Publicado 2015

Acral melanoma: new insights into the immune and genomic landscape

por Carvalho, Larissa Anastacio DaCosta, Aguiar, Flavia C., Smalley, Keiran S.M., Possik, Patricia A.
Publicado 2023

BRAF inhibition generates a host/tumor niche that mediates therapeutic escape

por Fedorenko, Inna V., Wargo, Jennifer A., Flaherty, Keith T., Messina, Jane L., Smalley, Keiran S.M.
Publicado 2015

HDAC11 activity contributes to MEK inhibitor escape in uveal melanoma

por Sriramareddy, Sathya Neelature, Faião-Flores, Fernanda, Emmons, Michael F., Saha, Biswarup, Chellappan, Srikumar, Wyatt, Clayton, Smalley, Inna, Licht, Jonathan D., Durante, Michael A., Harbour, J. William, Smalley, Keiran S.M.
Publicado 2022

C19MC miRNA-520G induces SP100 antiviral gene transcription and inhibits melanin production in skin cutaneous melanoma

por Jinesh, Goodwin G., Smallin, Marian T., Mtchedlidze, Nino, Godwin, Isha, Napoli, Marco, Hackel, Nicole, Phadke, Manali S., Deshpande, Avani A., Li, Xiaobo, Lockhart, John H., Baldwin, Jaden R., Acevedo-Acevedo, Suehelay, Gao, Yifeng, Reiser, Michelle A., Smalley, Keiran S.M., Flores, Elsa R., Brohl, Andrew S.
Publicado 2023

Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells

por Fedorenko, Inna V., Abel, Ethan V., Koomen, John M., Fang, Bin, Wood, Elizabeth R., Chen, Y. Ann, Fisher, Kate J., Iyengar, Sanjana, Dahlman, Kimberly B., Wargo, Jennifer A., Flaherty, Keith T., Sosman, Jeffrey A., Sondak, Vernon K., Messina, Jane L., Gibney, Geoffrey T., Smalley, Keiran S.M.
Publicado 2015

Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma

por Smalley, Inna, Kim, Eunjung, Li, Jiannong, Spence, Paige, Wyatt, Clayton J., Eroglu, Zeynep, Sondak, Vernon K., Messina, Jane L., Babacan, Nalan Akgul, Maria-Engler, Silvya Stuchi, De Armas, Lesley, Williams, Sion L., Gatenby, Robert A., Chen, Y. Ann, Anderson, Alexander R.A., Smalley, Keiran S.M.
Publicado 2019

Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4(+) Th1 Responses and Potential Use as a Cancer Vaccine

por Basu, Amrita, Albert, Gabriella K., Awshah, Sabrina, Datta, Jashodeep, Kodumudi, Krithika N., Gallen, Corey, Beyer, Amber, Smalley, Keiran S.M., Rodriguez, Paulo C., Duckett, Derek R., Forsyth, Peter A., Soyano, Aixa, Koski, Gary K., Lima Barros Costa, Ricardo, Han, Heather, Soliman, Hatem, Lee, Marie Catherine, Kalinski, Pawel, Czerniecki, Brian J.
Publicado 2022